ANGO

ANGIODYNAMICS INC

ANGO·03475V101·US·Common Stock·Healthcare - Medical Instruments & Supplies-13D/G

ANGO (ANGIODYNAMICS INC) is held by 97 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($49.5M), Point72 Asset Management, L.P. ($39.8M), ROYCE & ASSOCIATES LP ($25.6M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 54 funds bought ANGO.

97
Holders
(10 Elite)
$315.1M
Total Value
57% (95)
Consensus
54 buying - 41 selling
13F: Insider & Congress: Updated regularly
ANGO

Smart Money Verdict

View all
Loading verdict
Held by 97 funds
10 elite

Who's Trading

Source dates: Price Sep 22, 2026 · Insiders Oct 22, 2025 · Activists May 15, 2026 · Congress Oct 24, 2025

ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.7.7%May 15, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
ActivistARArmistice Capital, LLC6.0%Feb 17, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
3.8M(+3.2%)$49.5M0.0%+64.11%
30
Decreased
3.1M(-3.8%)$39.8M0.0%+52.33%
0
Increased
2M(+28.8%)$25.6M0.2%+65.48%
43
Decreased
1.7M(-1.9%)$22M0.0%+42.03%
0
Decreased
1.2M(-1.4%)$15.6M0.0%+49.22%
0
Increased
1M(+3.6%)$13.3M0.0%-0.26%
29
Increased
969,497(+2.2%)$12.6M0.0%+73.66%
29
Decreased
958,167(-28.2%)$12.5M0.0%+66.85%
0
Increased
783,125(+21.5%)$10.2M0.0%+52.68%
33
Decreased
733,883(-8.6%)$9.5M0.0%+55.58%
0
Decreased
692,534(-8.7%)$9M0.0%+55.49%
0
Increased
589,157(+134.2%)$7.7M0.0%+26.20%
44
Increased
552,870(+100.5%)$7.2M0.0%+124.17%
44
Increased
440,844(+1.0%)$5.7M0.0%+41.78%
27
Decreased
420,378(-13.4%)$5.5M0.0%+60.87%
0
Increased
382,917(+21.9%)$5M0.0%+48.36%
32
Increased
374,029(+11.8%)$4.9M0.0%-8.53%
30
Decreased
345,143(-31.5%)$4.5M0.0%+46.30%
0
Increased
329,727(+6.1%)$4.3M0.0%-27.22%
28
Increased
306,260(+32.9%)$4M0.0%+29.32%
34

Showing 1-20 of 106

1 / 6
ANGOANGOANGIODYNAMICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used